0930-AA38 202204 Unified Agenda of Federal Regulatory and Deregulatory Actions 0930 Substance Abuse and Mental Health Services Administration SAMHSA 0900 Department of Health and Human Services HHS Treatment of Opioid Use Disorder With Buprenorphine Utilizing Telehealth

In the face of an escalating overdose crisis and an increasing need to reach remote and underserved communities, extending the buprenorphine telehealth flexibility is of paramount importance. To permanently continue this flexibility among OTPs after the COVID-19 public health emergency ends, SAMHSA proposes to revise OTP regulations under 42 CFR part 8.

]]> Other Significant Previously Published in The Unified Agenda Proposed Rule Stage Yes No 42 CFR 8.11 (h) The Controlled Substances Act, as amended by the Ryan Haight Act (21 U.S.C. sec. 802(54)(G)) Yes NPRM 09/00/2022 No Businesses None No No No No Neeraj Gandotra Dr. Chief Medical Officer 0930 Substance Abuse and Mental Health Services Administration SAMHSA 202 823-1816 neeraj.gandotra@samhsa.hhs.gov 5600 Fishers Lane, 18E67, Rockville MD 20857